<code id='FE5DD3DE47'></code><style id='FE5DD3DE47'></style>
    • <acronym id='FE5DD3DE47'></acronym>
      <center id='FE5DD3DE47'><center id='FE5DD3DE47'><tfoot id='FE5DD3DE47'></tfoot></center><abbr id='FE5DD3DE47'><dir id='FE5DD3DE47'><tfoot id='FE5DD3DE47'></tfoot><noframes id='FE5DD3DE47'>

    • <optgroup id='FE5DD3DE47'><strike id='FE5DD3DE47'><sup id='FE5DD3DE47'></sup></strike><code id='FE5DD3DE47'></code></optgroup>
        1. <b id='FE5DD3DE47'><label id='FE5DD3DE47'><select id='FE5DD3DE47'><dt id='FE5DD3DE47'><span id='FE5DD3DE47'></span></dt></select></label></b><u id='FE5DD3DE47'></u>
          <i id='FE5DD3DE47'><strike id='FE5DD3DE47'><tt id='FE5DD3DE47'><pre id='FE5DD3DE47'></pre></tt></strike></i>

          fashion

          fashion

          author:Wikipedia    Page View:9
          Adobe

          It is one of health care’s most vexing quandaries: Patient data must be shared to develop more effective medicines and artificial intelligence tools, but there’s no way to share it without violating privacy and basic data rights.

          Or is there?

          advertisement

          A fresh crop of companies is building a new data economy that enables the shared use of personal health information while enforcing ironclad privacy protections. They are not a monolithic group: each one uses its own methods and technologies, serves different customers, and is motivated by distinct problems and personal philosophies.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more
          AstraZeneca chief proposes a novel edit to the drug pricing bill
          AstraZeneca chief proposes a novel edit to the drug pricing bill

          PascalSoriotofAstraZenecaSTATAmongthepharmaceuticalcompanies’manyobjectionstotheBidenadministration’

          read more
          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more

          Biotech execs pursue obesity drug boom: ‘It’s the early innings’

          ElaineChenofSTAT,upperleft,talkedaboutobesitydrugswith,clockwise,RaymondStevenofStructureTherapeutic